Skip to main content
OpenTrials
Completed

NCT Number: NCT02707003

Clinical Utility of Capnography in the PACU( Post-anaesthesia Care Unit)

Multi-center observational trial with study device blinded in order to assess in parallel standard monitoring and intervention practices related to management of respiratory compromise in the post-anaesthesia care unit (PACU)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Respiratory Depression Respiration Disorders Respiratory Insufficiency Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Toronto Western Hospital, Toronto, Ontario, Canada

Loading trial locations.

About this study

All Study device information is blinded to medical staff but the Study Coordinator will have full access to device measurements, alarms, notification and events via a local Wi-Fi hub sent to a portable tablet. The tablet Case Report Form (CRF) will allow all observation be inserted with a time stamp on the electronic device data. In addition, all electronic data will be collected from the bedside monitor.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult ≥ 18 years of age
  • ASA Score II - IV (American Society of Anaesthesiologists Score)
  • Patients booked for a surgical procedure requiring general anesthesia care
  • Expected duration of general anesthesia to be > 1.5 hours
  • Expected to receive intraoperative opioids
  • Expected to be transferred to the PACU from the operating room
  • Patients with an expected duration in the PACU ≥ 45 minutes
  • Expected to be transferred from the PACU to an in-patient setting

Exclusion criteria

  • Patients expected to be discharged from the hospital when discharged from the PACU
  • Subjects who will have oral/nasal surgery that may prevent wearing an oral/nasal capnography sampling filterline.
  • Subjects with a history of severe contact allergies that may cause a reaction to standard adhesive materials found in pulse oximetry sensors.
  • Patients with skin lesions or physical deformities that would prevent the application of finger sensors for optimal performance.
  • A female known to be pregnant.

Treatment and study plan

Primary outcomes

  1. Frequency of Respiratory Adverse Events in the PACU identified by capnography

    Time frame: Up to 2 hours in the PACU

    Identification by blinded capnography to understand the ventilation challenges of patient in the PACU during standard of care that does not include capnography. First tier is RN (Registered Nurse) level of notification for early intervention and second tier is level at which covering MD (Medical Doctor) might request notification:

    • High Respiration Rate >25 bpm for > 15 seconds (tier one) and >30 bpm for more than 30 seconds (tier two)
    • Low Respiration Rate < 8 bpm for more than 15 seconds and < 6 bpm for more than 30 seconds
    • High end tidal CO2 (EtCO2) > 55 mmHg for > 15 seconds and > 60 mmHg for more than 30 seconds
    • Low EtCO2 < 25 mmHg for > 15 seconds and < 25 mmHg for more than 30 seconds
    • High Heart Rate > 120/min for 15 seconds and >120/min for 30 seconds
    • Low Heart Rate < 40/min for 15 seconds and < 40/min for 30 seconds
    • SpO2 (oxygen saturation by pulse oximetry) /Hypoxemia < 90% for more than 15 seconds and< 90% for more than 30 seconds

Secondary outcomes

  1. Frequency of Critical Adverse Events (CRAE)

    Time frame: PACU and 24 hours post PACU

    Critical CRAE in the PACU or in 24 hour post PACU chart review:

    • Narcotic overdose that required an Opioid reversal
    • Partial airway obstruction that required an NMBA (neuromuscular blocking agent) antagonist
    • Respiratory Insufficiency that would require Non-invasive positive pressure ventilation, ambu bag mask assisted ventilation
    • Respiratory failure that would Invasive mechanical ventilation
    • Upper airway obstruction requiring airway support measures (oral or nasal) such as intubation, LMA (laryngeal mask airway), or airway
    • Respiratory insufficiency/failure that would require a transfer to the ICU
    • Cardiopulmonary arrest
    • Death due to respiratory/pulmonary related complications Other (free text that might capture aspiration, pneumothorax)

  2. Ventilation insufficiency on transfer from the PACU

    Time frame: At PACU discharge

    Population of patients leaving the PACU in early stage ventilation respiratory insufficiency as defined as etCO2 ≤ 25 mmHg or etCO2 ≥55 mmHg combined with low RR (respiratory rate) and hypotension within 15 minutes before transport out of the PACU.

Sponsors and collaborators

Lead sponsor

Medtronic - MITG

Industry

Registry information

Official study title

A Multi-Center Pilot Observational Trial to Quantify the Potential Clinical Utility of Capnography in the PACU

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Mar 11, 2016
Registry last updated
Jul 23, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.